Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000242811 | SCV000318405 | likely benign | Cardiovascular phenotype | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705384 | SCV000717760 | likely benign | not provided | 2020-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000628824 | SCV000749731 | likely benign | Primary dilated cardiomyopathy | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920010 | SCV004730137 | likely benign | TXNRD2-related disorder | 2022-07-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |